Welcome

J&J Says FTC Probing Antitrust Violations Over Remicade Drug

July 29, 2019, 11:12 PM

The Federal Trade Commission issued a civil investigative demand to Johnson & Johnson in June regarding its contracting practices for the arthritis drug, the company said in a regulatory filing on July 29.

©2019 Bloomberg L.P. All rights reserved. Used with permission

To read the full article log in.

Learn more about a Bloomberg Law subscription.